En savoir plus
A follow-up to Emerging Issues and Controversies in Infectious Diseases, this volume provides a comprehensive review of topical issues in infectious diseases, highlighting the controversies related to the newest findings and recommendations. Coverage includes trends and debates in HIV research, community-acquired pneumonia, H. pylori, progress in Hepatitis C treatment paired with the lack of progress on Hepatitis B, and the effects of climate change on infectious disease epidemiology, among others. This is an essential resource for practicing and academic physicians, investigators, residents, and fellows focused on infectious diseases, infection control, public health, and global health.
Table des matières
1. Prevention of HIV Infection.- 2. Immune Reconstitution Inflammatory Syndrome and Paradoxical Reaction.- 3. Issues in Community-acquired Pneumonia.- 4. Helicobacter pylori Infection: When Should It be Treated?.- 5. Major Advances in Hepatitis C Treatment, but not Hepatitis B.- 6. Infectious Complications of Biologic Agents.- 7. Climate Change: Impact on Health and Infectious Diseases Globally.- 8. Blood Transfusion-associated Infections in the 21st Century: New Challenges.- 9. Mass Drug Treatment of Tropical Diseases: Is It Really Progress?.- 10. Issues in Therapeutics of Some Bacterial Infections.- 11. Issues and Concerns in the Management of Systemic Candidiasis.- 12. Emerging and Difficult-to-Treat Nontuberculous Mycobacteria Infections.
A propos de l'auteur
Ignatius Fong is the Editor of Springer's
Emerging Infectious Diseases of the 21st Century series. He has served as Chief Editor for six books and the sole author for another six books published in the series. He completed his residency training in Internal Medicine at the University of Toronto and as a Fellow in Infectious Diseases at the University of Washington, Seattle. Dr. Fong has published studies concerning a variety of infectious diseases that include therapeutics and pharmacology of antibiotics, AIDS and the treatment of opportunistic infections, mechanistic and treatment studies of mucosal candidiasis, and pathogenic studies on infection and induction of atherosclerosis in animal models. He was Chief of Infectious Diseases at St. Michael's Hospital (Toronto) for 34 years; he is still on staff in Infectious Diseases and is a Professor of Medicine, Department of Medicine at the University of Toronto, Canada.
Commentaire
